a total of 151 patients with myeloma who had relapsed with or were resistant to melphalan and/or cyclophosphamide ( cytoxan ) with prednisone received vincristine , carmustine ( bcnu ) , doxorubicin ( adriamycin ) , and prednisone ( vbap ) at 21-day intervals ;
C0026764
myeloma
C0007257
vbap